Last week, Senators Chris Coons (D-Del.) and Thom Tillis (R-N.C.) introduced the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act, intended to protect consumers by stopping the online sale of harmful counterfeit products. This follows introduction of the same legislation by House Judiciary Committee Chairman Jerrold Nadler (D-N.Y.) and Congressmen Darrell Issa (R-Calif.), Henry C. "Hank" Johnson, Jr. (D-Ga.), and Ben Cline (R-Va.).
Senators Dick Durbin (D-Ill.) and Bill Cassidy, M.D. (R-La.) recently introduced legislation to combat the online sale of stolen, counterfeit, and dangerous consumer products by ensuring transparency of high-volume third-party sellers in online retail marketplaces.
During this episode, get a behind-the-scenes look at CHPA’s policy priorities and the role that the new Congress plays in shaping healthcare from CHPA’s Federal Government Affairs Vice President Marc Schloss and Director Taylor Holgate.
The American Cleaning Institute (ACI) and the Consumer Healthcare Products Association (CHPA) request that FDA withdraw its Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19).
CHPA is set to testify on Monday before the Massachusetts Joint Committee on Public Health. The hearing, which will be held virtually, is the first policy committee hearing for the Commonwealth’s legislature in 2021. Nearly 50 bills are scheduled to be considered during the hearing, including four bills on which CHPA will be testifying.
CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.